Investigators at the consortium Stillbirth Collaborative Research Network have developed a new system to assign the cause of death in stillbirths.
Investigators at the consortium Stillbirth Collaborative Research Network have developed a new system to assign the cause of death in stillbirths.
The study team conducted a complete evaluation of 512 stillbirths among 500 women, relying on postmortem examination, placental pathology, medical record abstraction, and maternal interview to determine clinical, pathologic, and pathophysiologic findings that might be considered the cause of death.
Using the data they collected, investigators then developed the Initial Causes of Fetal Death tool that incorporates known causes of stillbirths and designates them as possible or probable causes based on strict diagnostic criteria derived from published references and pathophysiologic sequences that lead to stillbirth. The tool encompasses 6 broad categories of causes of death: maternal medical conditions; obstetric complications; maternal or fetal hematologic conditions; fetal genetic, structural and karyotypic abnormalities; placental infection, fetal infection, or both; and placental pathologic findings.
Dudley DJ, Goldenberg R, Conway D, et al; Stillbirth Collaborative Research Network. A new system for determining the causes of stillbirth. Obstet Gynecol. 2010;116(2 pt 1):254-260.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More